These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7387491)

  • 1. Bromocriptine and buccolinguofacial dyskineasias in patients with senile dementia. A quantitative study.
    Delwaide PJ; Hurlet A
    Arch Neurol; 1980 Jul; 37(7):441-3. PubMed ID: 7387491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
    Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine on dystonic-athetoid dyskinesias in mentally retarded patients.
    Iivanainen M; Kaste M; Juntunen J; Kruus S; Ranta T; Seppälä M
    J Ment Defic Res; 1978 Sep; 22(3):193-6. PubMed ID: 702528
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials.
    Lobbezoo F; Soucy JP; Hartman NG; Montplaisir JY; Lavigne GJ
    J Dent Res; 1997 Sep; 76(9):1610-4. PubMed ID: 9294496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine in the treatment of parkinsonism.
    Parkes JD
    Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of bromocriptine in senile dementia].
    Borenstein P; Soret C; Graille D
    Ann Med Psychol (Paris); 1981 Mar; 139(3):326-34. PubMed ID: 7325489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
    Lander CM; Lees A; Stern G
    Clin Exp Neurol; 1979; 16():197-203. PubMed ID: 121706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of low doses of bromocriptine in chronic schizophrenia resistant to neuroleptics. A preliminary study].
    Wolf MA; Diener JM; Lajeunesse C; Shriqui C
    J Psychiatry Neurosci; 1992 Jun; 17(2):68-71. PubMed ID: 1637801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine: low-dose therapy in Parkinson disease.
    Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
    Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential tremor and buccolinguofacial dyskinesias.
    Martinelli P; Gabellini AS
    Acta Neurol Scand; 1982 Dec; 66(6):705-8. PubMed ID: 7164771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
    Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
    Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method.
    Jinno M; Katsumata Y; Hoshiai T; Nakamura Y; Matsumoto K; Yoshimura Y
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3603-11. PubMed ID: 9360514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations.
    Inzelberg R; Nisipeanu P; Rabey JM; Orlov E; Catz T; Kippervasser S; Schechtman E; Korczyn AD
    Neurology; 1996 Sep; 47(3):785-8. PubMed ID: 8797480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
    Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine for cocaine dependence. A controlled clinical trial.
    Handelsman L; Rosenblum A; Palij M; Magura S; Foote J; Lovejoy M; Stimmel B
    Am J Addict; 1997; 6(1):54-64. PubMed ID: 9097872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
    Agid Y; Pollak P; Bonnet AM; Signoret JL; Lhermitte F
    Lancet; 1979 Mar; 1(8116):570-2. PubMed ID: 85162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias.
    Mark MH; Sage JI
    Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose bromocriptine therapy in Parkinson's disease.
    Pfeiffer RF; Wilken K; Glaeske C; Lorenzo AS
    Arch Neurol; 1985 Jun; 42(6):586-8. PubMed ID: 4004603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine versus levodopa in early Parkinson's disease.
    Ramaker C; van Hilten JJ
    Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy.
    Katz E; Schran HF; Adashi EY
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):517-20. PubMed ID: 2915884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.